Market Exclusive

Analyst Activity – Royal Bank of Canada Reiterates Outperform on Medtronic (NYSE:MDT)

Analyst Ratings For Medtronic (NYSE:MDT)

Today, Royal Bank of Canada reiterated its Outperform rating on Medtronic (NYSE:MDT) with a price target of $92.00.

Some recent analyst ratings include

Dividend information for Medtronic (NYSE:MDT)

Medtronic (NYSE:MDT) pays an annual dividend of $1.84 with a yield of 2.30% and an average dividend growth of 15.00% based on a 3 Year Average..

Dividend History for Medtronic (NYSE:MDT)

Recent Insider Trading Activity For Medtronic (NYSE:MDT)
Medtronic (NYSE:MDT) has insider ownership of 0.31% and institutional ownership of 81.91%.

Recent Trading Activity for Medtronic (NYSE:MDT)
Shares of Medtronic closed the previous trading session at 79.91 down -0.31 0.39% with 80.29000091552734 shares trading hands.

Exit mobile version